Institute for Heart, Vascular and Stroke Care

Experts from the Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care present a dynamic symposium on systemic cardiovascular disease.

Novel Therapeutic Strategies for Systemic Cardiovascular Disease: An Integrated Approach to Treating
Heart Failure and Valve Disease, Vascular Disease and Stroke

Meet our speakers:

Course ChairmanKenneth Rosenfield, MD
Section Head, Vascular Medicine and Intervention

PresentersJoshua N. Baker, MD
Cardiac Surgery

Patrick Ellinor, MD
Director, Cardiac Arrhythmia/Step Down Unit

Sanjeev A. Francis, MD

Eric M. Isselbacher, MD
Associate Director, Corrigan Minehan Heart Center

Michael R. Jaff, DO

Chair, Institute for Heart, Vascular and Stroke Care

Christopher Kwolek, MD
Training Program Director, Vascular and Endovascular Surgery

Moussa Mansour, MD
Director, Cardiac Electrophysiology Laboratory

Natalia Rost, MD
Associate Director, Acute Stroke Service

Thoralf M. Sundt, MD
Chief, Division of Cardiac Surgery

Heart Venogram Brain
Course Description

Novel Therapeutic Strategies for Systemic Cardiovascular Disease: An Integrated Approach to Treating Heart Failure and Valve Disease, Vascular Disease and Stroke presents evidence-based strategies that will impact your practice performance and improve outcomes for your patients with cardiovascular disease. The expert faculty will provide insights and opinions on methods for providing comprehensive diagnosis, treatment and management of patients while working in an integrated, multispecialty program.

Course Objectives

  • Implement new strategies for the treatment of valvular heart disease
  • Describe the options for the latest therapies in atrial fibrillation and choose the appropriate therapy for an individual patient
  • Evaluate the role of coordinated care for the management of massive and submassive pulmonary embolism
  • Review current approaches in the treatment of thoracic aortic disease

Program Agenda

5:00 pm                       Registration/Dinner   

5:15 pm – 5:25 pm    Welcome/Agenda Overview

5:25 pm – 5:50 pm    Heart Valve Decision Making: The Impact of the
Percutaneous Option

5:50 pm – 6:00 pm    Q&A

6:00 pm – 6:25 pm    Emerging Therapies for Thoracic Aortic Disease:
The Link Between Medicine, Surgery and Endovascular Technologies

6:25 pm – 6:35 pm

6:35 pm – 7:00 pm   Pulmonary Embolism Response Team: The New,
Multidisciplinary Approach to Treatment

7:00 pm – 7:10 pm   Q&A

7:10 pm – 7:35 pm   Atrial Fibrillation and Stroke: Rapid Evolution of Treatment Opportunities

7:35 pm – 7:50 pm   Q&A

7:50 pm - 8:00 pm   Closing Remarks

Accreditation StatementThis activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Massachusetts General Hospital. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit DesignationThe Postgraduate Institute for Medicine designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of InterestPostgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.


This educational activity is not part of ACC.13; however, the content was reviewed and approved by the ACC.13 Program Committee.


Register for this CME